Bikam Pharmaceuticals
United States · $11.0M raised
- Business Model
- B2B
- Total Funding
- $11.0M
- Last Round
- $11.0M Series AJan 2020
- Rounds
- 1
About
Biopharmaceutical company developing novel small molecule therapies for retinal degenerative diseases with high unmet medical need.
Summary
Bikam Pharmaceuticals is a Biotech company based in United States. It has raised $11.0M in total across 1 round, most recently a $11.0M Series A round in Jan 2020. Investors include CHL Medical Partners, HealthCare and F-Prime Capital.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2020
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...